Viewing Study NCT06422403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-01 @ 4:48 AM
Study NCT ID: NCT06422403
Status: RECRUITING
Last Update Posted: 2025-01-10
First Post: 2024-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Sponsor: National University Hospital, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
None Gastric Adenocarcinoma View
None GastroEsophageal Cancer View
None Oesophageal Cancer View
None Non-small Cell Lung Cancer View
None Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nivolumab View
None Atezolizumab View
None Pembrolizumab View
None Extended dosing interval View